Filter by: patients
What is Creon 20?

Creon®20 is a brand of pancrelipase a digestive enzyme used for the treatment of exocrine pancreatic insufficiency (EPI) due to conditions such as cystic fibrosis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Cystic Fibrosis 2 0
Support digestive health 2 1 Efficacy_major
Pancreatic Insufficiency 1 0
Loose bowel movements 1 0

See all 6 patients currently taking Creon 20

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
1

Reported Dosages

  8 66,400units-20,000units-75,000units as needed 3 x 66,400 units-20,000 units-75,000 units daily 4 x 66,400 units-20,000 units-75,000 units daily 12 x 66,400 units-20,000 units-75,000 units daily 20 x 66,400 units-20,000 units-75,000 units daily 25 x 66,400 units-20,000 units-75,000 units daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Creon 20 (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 1   Other: 100%

See all 1 patient who’ve stopped taking Creon 20

Currently Taking Creon 20

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Creon 20

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Creon 20

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Burden of Creon 20

Very
0 0%
Somewhat
0 0%
A little
1 100%
Not at all
0 0%

Cost

Paid out of pocket

Cost of Creon 20

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 25, 2012.